Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.
about
Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent)Recent advances in granulosa cell tumor ovary: a reviewFOXO1/3 and PTEN Depletion in Granulosa Cells Promotes Ovarian Granulosa Cell Tumor Development.Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.Efficacy and safety of bevacizumab in recurrent sex cord-stromal ovarian tumors: results of a phase 2 trial of the Gynecologic Oncology Group.Anti-VEGFA Therapy Reduces Tumor Growth and Extends Survival in a Murine Model of Ovarian Granulosa Cell TumorRole of bevacizumab in colorectal cancer growth and its adverse effects: a review.Genetic changes in nonepithelial ovarian cancer.The extracellular matrix glycoprotein elastin microfibril interface located protein 2: a dual role in the tumor microenvironment.Ovarian Sex Cord-Stromal Tumors.The molecular mechanism of ovarian granulosa cell tumors.Laparoscopical management ovarian early sex cord-stromal tumors in postmenopausal women: a proposal method.Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature.
P2860
Q24195031-2F49739C-52AF-4346-B4AA-A27208D8B390Q28305857-25747DE3-6C77-4E38-94DA-894F2ADED58FQ30358011-6E8C9124-4752-474A-91CF-9CF2443299FCQ33778741-5C9F27EC-92FD-46B4-A216-76B25BC40CF0Q34600671-733501AF-88BE-477B-837E-910F132FAA80Q36865005-5251FD71-2C79-41CE-8224-4B219AE3DDD8Q37102447-F8D4F584-9E28-400B-BB01-C15B7A1E8E1AQ38123207-42D77C45-1452-4975-8E57-8194750E8404Q39856408-C8DBA7E5-A476-4EFB-B443-0399F7E2D0A5Q41651232-88A2C31E-AB91-4A2B-956D-074E4953C64EQ50156697-F6E63BFB-3B7E-4284-B80A-EE3E175B872EQ51741320-490CAE3B-0A4E-4E1E-84C7-05D0578F3776Q55266092-4A22AAA9-BA1F-41B0-B020-A2EDE6BF5897
P2860
Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@ast
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@en
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@nl
type
label
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@ast
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@en
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@nl
prefLabel
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@ast
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@en
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@nl
P2093
P2860
P1433
P1476
Anti-angiogenesis therapy with ...... ovarian granulosa cell tumors.
@en
P2093
Alpa M Nick
Anil K Sood
David M Gershenson
Jubilee Brown
Kathleen M Schmeler
Ljiljana Milojevic
Michael T Deavers
Robert L Coleman
P2860
P304
P356
10.1016/J.YGYNO.2009.04.021
P407
P577
2009-06-13T00:00:00Z